Ivermectin in Brazil – A tale of two studies (Part 2 – TOGETHER Trial)

The ivermectin arm of the TOGETHER Trial, which was undertaken in Brazil, was recently published in the New England Journal of Medicine (NEJM) and is the largest randomised controlled trial of ivermectin to date. Unlike the flawed trial undertaken in Itajai, which was discussed in part 1 and touted by ivermectin fans, such as Dr John Campbell and Dr Pierre Kory from the FLCCC, the TOGETHER Trial showed no benefit for ivermectin. Not happy with this, a number of ivermectin proponents have levelled numerous criticisms. In this video, Dr Susan Oliver goes back to the science and addresses these criticisms and shows why they are not valid.

Ivermectin in Brazil – A tale of two studies (Part 1 - Itajai)
https://www.youtube.com/watch?v=zXq6NAZ1mls

Buy me a coffee https://www.buymeacoffee.com/SusanAndJulie

Links to data:

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching
https://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching

Effect of Early Treatment with Ivermectin among Patients with Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2115869

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities - The I-TECH Randomized Clinical Trial
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext